Literature DB >> 31437719

Associations among amyloid status, age, and longitudinal regional brain atrophy in cognitively unimpaired older adults.

Rachel L Nosheny1, Philip S Insel2, Niklas Mattsson2, Duygu Tosun3, Shannon Buckley4, Diana Truran4, N Schuff4, Paul S Aisen5, Michael W Weiner6.   

Abstract

The goal of this study was to compare regional brain atrophy patterns in cognitively unimpaired (CU) older adults with and without brain accumulation of amyloid-β (Aβ) to elucidate contributions of Aβ, age, and other variables to atrophy rates. In 80 CU participants from the Alzheimer's Disease Neuroimaging Initiative, we determined effects of Aβ and age on longitudinal, regional atrophy rates, while accounting for confounding variables including sex, APOE ε4 genotype, white matter lesions, and cerebrospinal fluid total and phosphorylated tau levels. We not only found overlapping patterns of atrophy in Aβ+ versus Aβ- participants but also identified regions where atrophy pattern differed between the 2 groups. Higher Aβ load was associated with increased longitudinal atrophy in the entorhinal cortex, amygdala, and hippocampus, even when accounting for age and other variables. Age was associated with atrophy in insula, fusiform gyrus, and isthmus cingulate, even when accounting for Aβ. We found age by Aβ interactions in the postcentral gyrus and lateral orbitofrontal cortex. These results elucidate the separate and related effects of age, Aβ, and other important variables on longitudinal brain atrophy rates in CU older adults.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Alzheimer's disease; Amyloid-β; Brain atrophy

Mesh:

Substances:

Year:  2019        PMID: 31437719      PMCID: PMC7198229          DOI: 10.1016/j.neurobiolaging.2019.07.005

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  76 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Automatically parcellating the human cerebral cortex.

Authors:  Bruce Fischl; André van der Kouwe; Christophe Destrieux; Eric Halgren; Florent Ségonne; David H Salat; Evelina Busa; Larry J Seidman; Jill Goldstein; David Kennedy; Verne Caviness; Nikos Makris; Bruce Rosen; Anders M Dale
Journal:  Cereb Cortex       Date:  2004-01       Impact factor: 5.357

3.  Heterogeneity of neuroanatomical patterns in prodromal Alzheimer's disease: links to cognition, progression and biomarkers.

Authors:  Aoyan Dong; Jon B Toledo; Nicolas Honnorat; Jimit Doshi; Erdem Varol; Aristeidis Sotiras; David Wolk; John Q Trojanowski; Christos Davatzikos
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

4.  Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease.

Authors:  John C Morris; Catherine M Roe; Elizabeth A Grant; Denise Head; Martha Storandt; Alison M Goate; Anne M Fagan; David M Holtzman; Mark A Mintun
Journal:  Arch Neurol       Date:  2009-12

5.  Atrophy rates of entorhinal cortex in AD and normal aging.

Authors:  A T Du; N Schuff; X P Zhu; W J Jagust; B L Miller; B R Reed; J H Kramer; D Mungas; K Yaffe; H C Chui; M W Weiner
Journal:  Neurology       Date:  2003-02-11       Impact factor: 9.910

6.  Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease.

Authors:  P V Arriagada; K Marzloff; B T Hyman
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

7.  H-1 MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischemic vascular dementia.

Authors:  J M Constans; D J Meyerhoff; J Gerson; S MacKay; D Norman; G Fein; M W Weiner
Journal:  Radiology       Date:  1995-11       Impact factor: 11.105

8.  Does amyloid deposition produce a specific atrophic signature in cognitively normal subjects?

Authors:  Jennifer L Whitwell; Nirubol Tosakulwong; Stephen D Weigand; Matthew L Senjem; Val J Lowe; Jeffrey L Gunter; Bradley F Boeve; David S Knopman; Bradford C Dickerson; Ronald C Petersen; Clifford R Jack
Journal:  Neuroimage Clin       Date:  2013-01-24       Impact factor: 4.881

9.  18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease.

Authors:  Niklas Mattsson; Michael Schöll; Olof Strandberg; Ruben Smith; Sebastian Palmqvist; Philip S Insel; Douglas Hägerström; Tomas Ohlsson; Henrik Zetterberg; Jonas Jögi; Kaj Blennow; Oskar Hansson
Journal:  EMBO Mol Med       Date:  2017-09       Impact factor: 12.137

10.  Polygenic risk of Alzheimer disease is associated with early- and late-life processes.

Authors:  Elizabeth C Mormino; Reisa A Sperling; Avram J Holmes; Randy L Buckner; Philip L De Jager; Jordan W Smoller; Mert R Sabuncu
Journal:  Neurology       Date:  2016-07-06       Impact factor: 9.910

View more
  4 in total

1.  Associations Between Sub-Threshold Amyloid-β Deposition, Cortical Volume, and Cognitive Function Modulated by APOE ɛ4 Carrier Status in Cognitively Normal Older Adults.

Authors:  Dong Woo Kang; Sheng-Min Wang; Yoo Hyun Um; Nak Young Kim; Chang Uk Lee; Hyun Kook Lim
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

2.  Lateral Entorhinal Cortex Suppresses Drift in Cortical Memory Representations.

Authors:  Maryna Pilkiw; Justin Jarovi; Kaori Takehara-Nishiuchi
Journal:  J Neurosci       Date:  2021-12-15       Impact factor: 6.709

3.  Predicting amyloid status using self-report information from an online research and recruitment registry: The Brain Health Registry.

Authors:  Miriam T Ashford; John Neuhaus; Chengshi Jin; Monica R Camacho; Juliet Fockler; Diana Truran; R Scott Mackin; Gil D Rabinovici; Michael W Weiner; Rachel L Nosheny
Journal:  Alzheimers Dement (Amst)       Date:  2020-09-24

4.  Neuronal Code for Episodic Time in the Lateral Entorhinal Cortex.

Authors:  Kaori Takehara-Nishiuchi
Journal:  Front Integr Neurosci       Date:  2022-04-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.